Elizabeth Anderson

Q: What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of 93.740734296593.

Q: What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of 23.85009604501764.

Evercore ISI Group | Healthcare

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector. Ranked #1053 out of 4771 analysts, they have issued 54 stock ratings with a success rate of 93.74% and an average return of 23.85%.

Elizabeth Anderson has a well-established track record, with 54 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.74% and an average return of 23.85%, underscoring their expertise and ability to identify winning opportunities for investors.

#1053

Out of 4771

Total Ratings

+93.74%

Success Rate

+23.85%

Average Return

Recent Ratings Analysis

HNGE

Buy

Aug 05, 2026

Target

$105.00

Current

$88.26

Performance

9.25%

Elizabeth Anderson rated HNGE as Outperform on Aug 05, 2026, setting a price target of 105. The call has proven timely, with shares rising 9.25% toward the price target of 105.

FTRE

Buy

Jul 30, 2026

Target

$25.00

Current

$17.02

Performance

-10.80%

On Jul 30, 2026, FTRE was given a Outperform rating by Elizabeth Anderson, with a target price of 25. Despite the Buy call, shares fell from 17.02 to 17.02, challenging the optimistic stance.

TDOC

Hold

Jul 30, 2026

Target

$7.50

Current

$6.09

Performance

-7.45%

TDOC received a In-Line rating from Elizabeth Anderson on Jul 30, 2026, aiming for 7.5. The Hold stance proved prudent, with the market softening by 7.45%.

GMRS

Buy

Jun 08, 2026

Target

$20.00

Current

$12.47

Performance

17.86%

On Jun 08, 2026, Elizabeth Anderson published a Outperform outlook on GMRS, with a target of 20. Shares gained 17.86%, underscoring the accuracy of the bullish outlook toward 20.

OMDA

Buy

May 08, 2026

Target

$20.00

Current

$21.50

Performance

45.07%

Elizabeth Anderson on May 08, 2026 assigned OMDA a Outperform rating, with a price target of 20. The Buy call aligned well with market performance, producing a gain of 45.07%.

MCK

Buy

May 08, 2026

Target

$850.00

Current

$880.86

Performance

19.67%

On May 08, 2026, Elizabeth Anderson reaffirmed MCK with a Outperform rating, targeting 850. The recommendation was supported by strong follow-through as the stock rose from 880.86 to 880.86.

CVS

Buy

May 07, 2026

Target

$105.00

Current

$95.29

Performance

9.08%

CVS was rated Outperform by Elizabeth Anderson on May 07, 2026, with a price objective of 105. A bullish response from the market helped close the gap of 9.71 to the target.

AGL

Hold

May 07, 2026

Target

$32.00

Current

$92.60

Performance

52.65%

On May 07, 2026, Elizabeth Anderson initiated coverage on AGL with a In-Line rating and target of 32. The Hold stance underestimated the stock’s strength as it gained 52.65%.

NVST

Buy

May 07, 2026

Target

$33.00

Current

$25.87

Performance

6.50%

Elizabeth Anderson issued a Outperform recommendation for NVST on May 07, 2026, price target set at 33. Investors following the Buy call captured upside momentum, with shares now at 25.87.

ALGN

Buy

Apr 30, 2026

Target

$220.00

Current

$150.72

Performance

-14.37%

On Apr 30, 2026, ALGN was evaluated by Elizabeth Anderson, who gave a Outperform rating and target of 220. Investors saw limited payoff as shares fell short of the 220 target.

ELV

Hold

Apr 23, 2026

Target

$360.00

Current

$416.54

Performance

20.29%

Elizabeth Anderson rated ELV as In-Line on Apr 23, 2026, setting a price target of 360. Despite the Hold call, shares climbed 20.29% to 416.54, revealing unexpected momentum.

PRVA

Buy

Apr 08, 2026

Target

$26.00

Current

$20.37

Performance

-10.30%

On Apr 08, 2026, PRVA was given a Outperform rating by Elizabeth Anderson, with a target price of 26. Despite the Buy call, shares fell from 20.37 to 20.37, challenging the optimistic stance.

DOCS

Hold

Apr 08, 2026

Target

$25.00

Current

$24.71

Performance

13.04%

DOCS received a In-Line rating from Elizabeth Anderson on Apr 08, 2026, aiming for 25. Investors saw gains of 13.04% that the cautious stance didn’t fully capture.

CAH

Buy

Apr 08, 2026

Target

$240.00

Current

$236.02

Performance

9.71%

On Apr 08, 2026, Elizabeth Anderson published a Outperform outlook on CAH, with a target of 240. Shares gained 9.71%, underscoring the accuracy of the bullish outlook toward 240.

DGX

Hold

Apr 08, 2026

Target

$210.00

Current

$231.14

Performance

16.26%

Elizabeth Anderson on Apr 08, 2026 assigned DGX a In-Line rating, with a price target of 210. Shares outperformed expectations, climbing 16.26% despite the neutral view.

HSIC

Buy

Apr 08, 2026

Target

$90.00

Current

$87.30

Performance

15.58%

On Apr 08, 2026, Elizabeth Anderson reaffirmed HSIC with a Outperform rating, targeting 90. The recommendation was supported by strong follow-through as the stock rose from 87.3 to 87.3.

IQV

Buy

Apr 08, 2026

Target

$185.00

Current

$257.30

Performance

49.12%

IQV was rated Outperform by Elizabeth Anderson on Apr 08, 2026, with a price objective of 185. A bullish response from the market helped close the gap of -72.30 to the target.

LH

Buy

Apr 08, 2026

Target

$300.00

Current

$306.96

Performance

11.74%

On Apr 08, 2026, Elizabeth Anderson initiated coverage on LH with a Outperform rating and target of 300. The stock’s climb of 11.74% since the call highlights the foresight in the rating.

XRAY

Hold

Feb 27, 2026

Target

$15.00

Current

$10.50

Performance

-28.47%

Elizabeth Anderson issued a In-Line recommendation for XRAY on Feb 27, 2026, price target set at 15. Market action validated the conservative Hold outlook with shares at 10.5.

MDLN

Buy

Feb 26, 2026

Target

$55.00

Current

$32.39

Performance

-33.75%

On Feb 26, 2026, MDLN was evaluated by Elizabeth Anderson, who gave a Outperform rating and target of 55. Investors saw limited payoff as shares fell short of the 55 target.

WAY

Buy

Feb 18, 2026

Target

$40.00

Current

$23.06

Performance

-9.25%

Elizabeth Anderson rated WAY as Outperform on Feb 18, 2026, setting a price target of 40. The stock has underperformed, dropping 9.25% despite the bullish target of 40.

HCAT

Hold

Oct 08, 2025

Target

$3.00

Current

$1.73

Performance

-39.30%

On Oct 08, 2025, HCAT was given a In-Line rating by Elizabeth Anderson, with a target price of 3. The rating provided protection from downside risk as the stock fell to 1.73.

WBA

Hold

Jan 13, 2025

Target

$12.00

Current

$11.98

Performance

0.67%

WBA received a In-Line rating from Elizabeth Anderson on Jan 13, 2025, aiming for 12. Shares remained flat at 11.98, aligning with the neutral rating.

Frequency Asked Questions

Who is Elizabeth Anderson?

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector.

What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of +93.74%.

How many ratings has Elizabeth Anderson issued?

Elizabeth Anderson has issued 54 stock ratings so far.

What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of +23.85%.

What is Elizabeth Anderson's ranking?

Elizabeth Anderson is ranked #1053 out of 4771 analysts.

What types of ratings does Elizabeth Anderson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Elizabeth Anderson?

You can follow Elizabeth Anderson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Elizabeth Anderson?

Their latest rating was a Buy on HNGE issued on 2026-08-05.